Federal Register / Vol. 66, No. 102 / Friday, May 25, 2001 / Notices 28913

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

Disease, Disability, and Injury

Prevention and Control Special

Emphasis Panel (SEP): Extended Work

Schedules in the New Economy:

Health and Safety Risks to Workers;

RFA OH–01–006

In accordance with section 10(a)(2) of

the Federal Advisory Committee Act

(Pub. L. 92–463), the Centers for Disease

Control and Prevention (CDC)

announces the following meeting:

Name: Disease, Disability, and Injury

Prevention and Control Special Emphasis

Panel (SEP): Extended Work Schedules in the

New Economy: Health and Safety Risks to

Workers; RFA OH–01–006.

Times and Dates: 8 a.m.–8:30 a.m., June

11, 2001. (Open) 8:30 a.m.–5 a.m., June 11,

2001. (Closed) 8:30 a.m.–5 a.m., June 12,

2001. (Closed)

Place: Sheraton Station Square, 7 Station

Square Drive, Pittsburgh, PA 15219

Status: Portions of the meeting will be

closed to the public in accordance with

provisions set forth in section 552b(c) (4) and

(6), Title 5 U.S.C., and the Determination of

the Deputy Director for Program

Management, CDC, pursuant to Public Law

92–463.

Matters to be Discussed: The meeting will

include the review, discussion, and

evaluation of applications received in

response to Program Announcement: RFA

OH–01–006.

For Further Information Contact: Pervis C.

Major, Ph.D., Scientific Review

Administrator, National Institute for

Occupational Safety and Health, CDC, 1095

Willowdale Road, M/S B228, Morgantown,

West Virginia 26505, telephone 304–285–

5979.

The Director, Management Analysis and

Services Office has been delegated the

authority to sign Federal Register notices

pertaining to announcements of meetings and

other committee management activities, for

both the Centers for Disease Control and

Prevention and the Agency for Toxic

Substances and Disease Registry.

Dated: May 21, 2001.

Carolyn J. Russell,

Director, Management Analysis and Service

Office, Centers for Disease Control and

Prevention (CDC).

[FR Doc. 01–13239 Filed 5–24–01; 8:45 am]

BILLING CODE 4163–19–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

Advisory Committee on Immunization

Practices: Meeting

In accordance with section 10(a)(2) of

the Federal Advisory Committee Act

(Pub. L. 92–463), the Centers for Disease

Control and Prevention (CDC)

announces the following committee

meeting:

Name: Advisory Committee on

Immunization Practices (ACIP).

Times and Dates: 8:30 a.m.–6:45 p.m., June

20, 2001.

8 a.m.–5:15 p.m., June 21, 2001.

Place: Atlanta Marriott Century Center,

2000 Century

Boulevard, N.E., Atlanta, Georgia 30345–

3377.

Status: Open to the public, limited only by

the space available.

Purpose: The Committee is charged with

advising the Director, CDC, on the

appropriate uses of immunizing agents. In

addition, under 42 U.S.C. 1396s, the

Committee is mandated to establish and

periodically review and, as appropriate,

revise the list of vaccines for administration

to vaccine-eligible children through the

Vaccines for Children (VFC) program, along

with schedules regarding the appropriate

periodicity, dosage, and contraindications

applicable to the vaccines.

Matters to be Discussed: The agenda will

include a discussion on vaccine safety issues

for yellow fever vaccine: Is a yellow fever

vaccine booster needed every 10 years; adult

high-risk hepatitis B immunization; current

epidemiology of HBV infection in the US;

status of immunization of high risk persons

in STD clinics, prisons, and non-traditional

settings; update on tetanus toxoid vaccine

shortage; what should be CDC’s role if the

influenza vaccine supply remains unclear for

the 2001–2002 season; summary of the liveattenuated influenza vaccine working group

meeting; vaccine safety updates: the Brighton

collaboration, Institute of Medicine Report on

measles, mumps and rubella vaccine and

autism; update on thimerosal; update from

the National Center for Infectious Diseases;

update from the National Immunization

Program; update from the Food and Drug

Administration; update from the National

Institutes of Health; update from the Vaccine

Injury Compensation Program; update from

the National Vaccine Program; final decision

on general recommendations for

immunization; discontinuation of human

rabies vaccine for intradermal pre-exposure

use; update on current phase III HIV vaccine

efficacy trials; update on risk of

meningococcal disease among microbiology

laboratory workers; use of economic

evaluation for setting health policy;

recommended childhood immunization

schedule, 2002; and should there be an

immunization schedule for adult

immunization.

Agenda items are subject to change as

priorities dictate.

For Further Information Contact: Gloria A.

Kovach, Program Analyst, Epidemiology and

Surveillance Division, National

Immunization Program, CDC, 1600 Clifton

Road, NE, m/s E61, Atlanta, Georgia 30333.

Telephone 404/639–8096.

The Director, Management Analysis and

Services office has been delegated the

authority to sign Federal Register notices

pertaining to announcements of meetings and

other committee management activities for

both the Centers for Disease Control and

Prevention and the Agency for Toxic

Substances and Disease Registry.

Dated: May 21, 2001.

Carolyn J. Russell,

Director, Management Analysis and Services

Office, Centers for Disease Control and

Prevention.

[FR Doc. 01–13238 Filed 5–24–01; 8:45 am]

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

Notice of Meeting

In accordance with section 10(a)(2) of

the Federal Advisory Committee Act

(Pub. L. 92–463), the Centers for Disease

Control and Prevention (CDC)

announces the following committee

meeting:

Name: Safety and Occupational Health

Study Section (SOHSS), National Institute for

Occupational Safety and Health (NIOSH).

Times and Dates: 8:30 a.m.–5:30 p.m., June

28, 2001; 8 a.m.–5 p.m., June 29, 2001.

Place: Embassy Suites, 1900 Diagonal

Road, Alexandria, VA, 22314.

Status: Open 8:30 a.m.–9:30 a.m., June 28,

2001; Closed 9:30 a.m.–5:30 p.m., June 28,

2001; Closed 8 a.m.–5 p.m., June 29, 2001.

Purpose: The Safety and Occupational

Health Study Section will review, discuss,

and evaluate grant application(s) received in

response to the Institute’s standard grants

review and funding cycles pertaining to

research issues in occupational safety and

health and allied areas.

It is the intent of NIOSH to support broadbased research endeavors in keeping with the

Institute’s program goals which will lead to

improved understanding and appreciation for

the magnitude of the aggregate health burden

associated with occupational injuries and

illnesses, as well as to support more focused

research projects which will lead to

improvements in the delivery of occupational

safety and health services and the prevention

of work-related injury and illness. It is

anticipated that research funded will

promote these program goals.

Matters to be Discussed: The meeting will

convene in open session from 8:30–9:30 a.m.

on June 28, 2001, to address matters related

to the conduct of Study Section business.

The remainder of the meeting will proceed in

closed session. The purpose of the closed

sessions is for the Safety and Occupational

28914 Federal Register / Vol. 66, No. 102 / Friday, May 25, 2001 / Notices

Health Study Section to consider safety and

occupational health related grant

applications. These portions of the meeting

will be closed to the public in accordance

with provisions set forth in section 552b(c)(4)

and (6) title 5 U.S.C., and the Determination

of the Associate Director for Management and

Operations, CDC, pursuant to Pub. L. 92–463.

Agenda items are subject to change as

priorities dictate.

For Further Information Contact: Charles

N. Rafferty, Ph.D., NIOSH Scientific Review

Administrator, Bethesda, Maryland.

Telephone (301)435–3562, E-mail

raffertc@csr.nih.gov.

The Director, Management Analysis and

Services Office has been delegated the

authority to sign Federal Register notices

pertaining to announcements of meetings and

other committee management activities, for

both the Centers for Disease Control and

Prevention and the Agency for Toxic

Substances and Disease Registry.

Dated: May 21, 2001.

Carolyn J. Russell,

Director, Management Analysis and Services

Office, Centers for Disease Control and

Prevention.

[FR Doc. 01–13237 Filed 5–24–01; 8:45 am]

BILLING CODE 4163–19–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Administration for Children and

Families

Proposed Information Collection

Activity; Comment Request

Proposed Projects

Title: Statewide Automated Child

Welfare Information System (SACWIS)

Assessment Review GuidE (SARGE).

OMB No. 0970–0159.

Description: HHS cannot fulfill its

obligation to effectively serve the

nation’s Adoption and Foster Care

populations, nor report meaningful and

reliable information to Congress about

the extent of problems facing these

children or the effectiveness of

assistance provided to this population,

without access to timely and accurate

information. Currently, SACWIS

systems support State efforts to meet the

following Federal reporting

requirements: the Adoption and Foster

Care Analysis and Reporting System

(AFCARS) required by section 479(b)(2)

of the Social Security Act; the National

Child Abuse and Neglect Data System

(NCANDS); Child Abuse Prevention and

Treatment Act (CAPTA); and the new

Chafee Independent Living Program.

Forty-eight States and the District of

Columbia have developed or have

committed to develop a SACWIS system

with Federal financial participation.

The purpose of these reviews is to

ensure that all aspects of the project, as

described in the approved Advance

Planning Document, have been

adequately completed, and conform to

applicable regulations and policies.

To initiate a review, States will

submit the completed SACWIS

Assessment Review GuidE (SARGE) and

other documentation at the point that

they have completed system

development and the system is

operational statewide. The additional

documents submitted as part of this

process should all be readily available

to the State as a result of good project

management.

The information collected in the

SACWIS Assessment Review Guide will

allow State and Federal officials to

determine if the State’s SACWIS system

meets the requirements for title IV–E

Federal financial participation defined

at 45 CFR 1355.50. Additionally, other

States will be able to use the

documentation provided as part of this

review process in their own system

development efforts.

Respondents: State Title IV–E

Agencies.

ANNUAL BURDEN ESTIMATES

Instrument Number of

respondents

Number of

responses per

respondent

Average burden hours per

response

Total burden

hours

Review ............................................................................................................. 6 1 200 1200

Estimated Total Annual Burden Hours ..................................................... ........................ ........................ ........................ 1200

In compliance with the requirements

of Section 3506(c)(2)(A) of the

Paperwork Reduction Act of 1995, the

Administration for Children and

Families is soliciting public comment

on the specific aspects of the

information collection described above.

Copies of the proposed collection of

information can be obtained and

comments may be forwarded by writing

to the Administration for Children and

Families, Office of Information Services,

370 L’Enfant Promenade, SW.,

Washington, DC 20447, Attn: ACF

Reports Clearance Officer. All requests

should be identified by the title of the

information collection.

The Department specifically requests

comments on: (a) whether the proposed

collection of information is necessary

for the proper performance of the

functions of the agency, including

whether the information shall have

practical utility; (b) the accuracy of the

agency’s estimate of the burden of the

proposed collection of information; (c)

the quality, utility, and clarity of the

information to be collected; and (d)

ways to minimize the burden of the

collection of information on

respondents, including through the use

of automated collection techniques or

other forms of information technology.

Consideration will be given to

comments and suggestions submitted

within 60 days of this publication.

Dated: May 22, 2001.

Bob Sargis,

Reports Clearance Officer.

[FR Doc. 01–13257 Filed 5–24–01; 8:45 am]

BILLING CODE 4184–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Food and Drug Administration

Oncologic Drugs Advisory Committee;

Notice of Meeting

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice.

This notice announces a forthcoming

meeting of a public advisory committee

of the Food and Drug Administration

(FDA). At least one portion of the

meeting will be closed to the public.

Name of Committee: Oncologic Drugs

Advisory Committee.

General Function of the Committee:

To provide advice and

recommendations to the agency on

FDA’s regulatory issues.